Literature DB >> 7000603

Endocrine pancreatic control of the release of gastric inhibitory polypeptide. A possible physiological role for C-peptide.

J R Dryburgh, S M Hampton, V Marks.   

Abstract

Intravenous infusion in anaesthetized rats of rat II C-peptide at a dose which produced circulating levels of 22.8 +/- 1.8 nmol/l after 30 min, resulted in a significant reduction (141 +/- 7 to 50 +/- 4 pmol/l, p < 0.001, mean +/- SEM) in the immunoreactive gastric inhibitory polypeptide response to an intestinal perfusion with a fat emulsion. Immunoreactive insulin levels were unchanged from basal in this study. It is suggested that C-peptide must be considered as a candidate for the endocrine pancreatic factor which exerts a negative feedback upon gastric inhibitory polypeptide release.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000603     DOI: 10.1007/bf00280527

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances.

Authors:  I G Cleator; R H Gourlay
Journal:  Am J Surg       Date:  1975-08       Impact factor: 2.565

Review 2.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

3.  Liver glycogen metabolism during intestinal perfusion in the rat.

Authors:  C Watts; L Morgan; V Marks
Journal:  Life Sci       Date:  1978-12-11       Impact factor: 5.037

Review 4.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

5.  Gut hormones in tropical malabsorption.

Authors:  H S Besterman; G C Cook; D L Sarson; N D Christofides; M G Bryant; M Gregor; S R Bloom
Journal:  Br Med J       Date:  1979-11-17

6.  Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency.

Authors:  R Ebert; W Creutzfeldt; J C Brown; H Frerichs; R Arnold
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

7.  Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues.

Authors:  S Sykes; L M Morgan; J English; V Marks
Journal:  J Endocrinol       Date:  1980-05       Impact factor: 4.286

8.  Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.

Authors:  W Creutzfeldt; M Talaulicar; R Ebert; B Willms
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

9.  On the biosynthesis, intracellular transport and mechanism of conversion of proinsulin to insulin and C-peptide.

Authors:  W Kemmler; J D Peterson; A H Rubenstein; D F Steiner
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

10.  Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.

Authors:  R Ebert; R Arnold; W Creutzfeldt
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

View more
  5 in total

Review 1.  New developments in the incretin concept.

Authors:  W Creutzfeldt; R Ebert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

2.  Effects of synthetic rat C-peptide in normal and diabetic rats.

Authors:  C Wójcikowski; V Maier; K Dominiak; R Fussgänger; E F Pfeiffer
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

3.  Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats.

Authors:  S M Hampton; P Kwasowski; K Tan; L M Morgan; V Marks
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

4.  A specific and sensitive radioimmunoassay for rat C-peptide.

Authors:  J O Akpan; L G Weide; R L Gingerich
Journal:  Int J Pancreatol       Date:  1993-04

Review 5.  Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3.

Authors:  Yasuo Ido
Journal:  J Diabetes Investig       Date:  2016-03-14       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.